Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Investing Ideas
Browse All Stocks
Markets
Investing Ideas
›
ROE over 20
Edit Screener
Get New Stock Alert
ROE over 20
Results
27
Companies with Return on Equity over 20%
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Pharmaceuticals & Biotech
All Industries
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
27 companies
0 new companies last 7d
Company
Last Price
7D Return
1Y Return
Market Cap
Analysts Target
Valuation
Growth
Div Yield
JNJ
Johnson & Johnson
US$240.87
3.8%
55.2%
US$579.8b
US$252.87
PE
27.6
E
8.3%
2.2%
GILD
Gilead Sciences
US$125.59
-2.0%
13.3%
US$155.9b
US$157.57
PE
16.9
E
20.9%
2.6%
BMY
Bristol-Myers Squibb
US$57.13
2.8%
17.4%
US$116.7b
US$63.08
PE
16.0
E
-1.8%
4.4%
VRTX
Vertex Pharmaceuticals
US$444.93
0.4%
-1.3%
US$112.9b
US$548.69
PE
26.0
E
13.0%
n/a
IQV
IQVIA Holdings
US$181.46
-1.1%
15.7%
US$30.3b
US$226.95
PE
21.9
E
13.1%
n/a
ILMN
Illumina
US$160.97
1.9%
78.4%
US$24.4b
US$147.17
PE
28.6
E
10.0%
n/a
UTHR
United Therapeutics
US$545.96
0.2%
89.2%
US$23.2b
US$665.23
PE
18.0
E
15.3%
n/a
INCY
Incyte
US$108.53
6.0%
60.2%
US$21.7b
US$109.09
PE
15.1
E
-15.3%
n/a
EXEL
Exelixis
US$53.13
2.7%
27.3%
US$13.4b
US$49.00
PE
16.0
E
12.1%
n/a
LQDA
Liquidia
US$71.23
15.2%
405.2%
US$6.3b
US$66.13
PE
284.0
E
29.3%
n/a
CPRX
Catalyst Pharmaceuticals
US$31.36
0.3%
32.5%
US$3.8b
US$31.67
PE
17.3
E
9.7%
n/a
ACAD
ACADIA Pharmaceuticals
US$21.09
-2.8%
-4.7%
US$3.6b
US$31.65
PE
9.6
E
12.1%
n/a
OGN
Organon
US$13.44
0.4%
31.9%
US$3.5b
US$11.25
PE
14.3
E
30.6%
0.6%
ADMA
ADMA Biologics
US$8.21
1.9%
-59.8%
US$1.9b
US$17.60
PE
11.5
E
20.5%
n/a
INVA
Innoviva
US$22.74
1.8%
4.3%
US$1.7b
US$35.50
PE
3.3
E
-22.3%
0%
PAHC
Phibro Animal Health
US$31.53
-2.8%
31.8%
US$1.3b
US$45.60
PE
13.4
E
15.1%
1.5%
COLL
Collegium Pharmaceutical
US$34.64
3.8%
18.7%
US$1.1b
US$54.33
PE
15.0
E
41.9%
n/a
TBPH
Theravance Biopharma
US$16.64
2.1%
54.8%
US$857.8m
US$17.40
PE
7.5
E
-19.2%
n/a
CRMD
CorMedix
US$8.74
2.3%
-39.1%
US$685.7m
US$15.20
PE
3.8
E
-4.5%
n/a
NNNN
Anbio Biotechnology
US$15.59
-32.2%
80.0%
US$684.3m
n/a
PE
106.9
n/a
n/a
XOMA
XOMA Royalty
US$41.79
-0.3%
72.2%
US$524.1m
US$39.00
PE
26.3
E
-4.8%
n/a
ABEO
Abeona Therapeutics
US$5.53
1.3%
-10.2%
US$315.2m
US$19.71
PE
4.8
E
32.9%
n/a
CGEN
Compugen
US$2.04
-2.9%
24.4%
US$193.0m
US$4.60
PE
5.5
E
-34.4%
n/a
PLX
Protalix BioTherapeutics
US$2.09
6.6%
46.2%
US$168.4m
US$11.00
PE
11.0
E
-69.2%
n/a
Page 1 of 1
Dashboard
Portfolios
Watchlist
Community
Discover
Screener
EN